CCL2, C-C motif chemokine ligand 2, 6347

N. diseases: 1157; N. variants: 8
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0742343
Disease: Acute Chest Syndrome
Acute Chest Syndrome
0.050 Biomarker disease BEFREE Transcoronary (TC) levels of chemokine ligand 2 (CCL2) and C-X3-C motif chemokine ligand 1 (CX3CL1) were significantly elevated in patients with ACS versus patients with SAP (P < 0.01). 31409556 2019
CUI: C0742343
Disease: Acute Chest Syndrome
Acute Chest Syndrome
0.050 Biomarker disease BEFREE Our study examined the prognostic value of Chemokine (C-C motif) ligand 2 (CCL2) in patients with ACS in the ERICO (Strategy of Registry of Acute Coronary Syndrome) study. 30551392 2019
CUI: C0742343
Disease: Acute Chest Syndrome
Acute Chest Syndrome
0.050 AlteredExpression disease BEFREE Follow-up measurement of VEGF, π-GST, and MCP-1 levels may provide a better tool for noninvasive assessment of renal parenchyma in newborns with ACS. 29053704 2018
CUI: C0742343
Disease: Acute Chest Syndrome
Acute Chest Syndrome
0.050 Biomarker disease BEFREE A cohort (84 females/132 males) from our 1996 ACS study population that had EDTA specimens stored (-70 degrees C) was selected and the earliest available specimen was analyzed for 11 biomarkers (IL-6, IL-8, MCP-1, VEGF, L-selectin, P-selectin, E-selectin, ICAM-1, VCAM-1, NT-proBNP, cTnT). 17964560 2008
CUI: C0742343
Disease: Acute Chest Syndrome
Acute Chest Syndrome
0.050 Biomarker disease BEFREE Atorvastatin reduced plasma MCP-1 concentrations in patients with ACS. 14637261 2003